FEDERICO
PULIDO ORTEGA
Profesor asociado de Ciencias de la Salud
Kaiser Permanente San Francisco Medical Center
San Francisco, Estados UnidosPublications in collaboration with researchers from Kaiser Permanente San Francisco Medical Center (1)
2017
-
Efficacy and safety of daclatasvir plus pegylated-interferon alfa 2a and ribavirin in previously untreated HCV subjects coinfected with HIV and HCV genotype-1: a Phase III, open-label study
Hepatology International, Vol. 11, Núm. 2, pp. 188-198